Pulmonary Pharmacology & Therapeutics

Papers
(The median citation count of Pulmonary Pharmacology & Therapeutics is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients63
Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects52
Myricetin inhibits TNF-α-induced inflammation in A549 cells via the SIRT1/NF-κB pathway48
Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life45
The immunomodulatory effects of macrolide antibiotics in respiratory disease39
Antihistamines and azithromycin as a treatment for COVID-19 on primary health care – A retrospective observational study in elderly patients34
Asthmatic children and MDI verbal inhalation technique counseling33
Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-1932
Mdivi-1 attenuates lipopolysaccharide-induced acute lung injury by inhibiting MAPKs, oxidative stress and apoptosis30
Small-molecule drugs for cystic fibrosis: Where are we now?26
The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination23
Baicalin ameliorates cigarette smoke-induced airway inflammation in rats by modulating HDAC2/NF-κB/PAI-1 signalling22
Bergenin-activated SIRT1 inhibits TNF-α-induced proinflammatory response by blocking the NF-κB signaling pathway21
Glucagon-like peptide 1 receptor (GLP-1R) agonist relieved asthmatic airway inflammation via suppression of NLRP3 inflammasome activation in obese asthma mice model21
Inhaled nintedanib is well-tolerated and delivers key pharmacokinetic parameters required to treat bleomycin-induced pulmonary fibrosis20
Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery20
Aerosolized Beractant in neonatal respiratory distress syndrome: A randomized fixed-dose parallel-arm phase II trial20
Effects of corticosteroids on Covid-19 patients: A systematic review and meta-analysis on clinical outcomes18
Tetrahydropalmatine protects against acute lung injury induced by limb ischemia/reperfusion through restoring PI3K/AKT/mTOR-mediated autophagy in rats17
Glabridin attenuates airway inflammation and hyperresponsiveness in a mice model of ovalbumin-induced asthma17
Significant improvement in lung function and asthma control after benralizumab treatment for severe refractory eosinophilic asthma16
Guanosine and uridine alleviate airway inflammation via inhibition of the MAPK and NF-κB signals in OVA-induced asthmatic mice16
Common molecular pathways targeted by nintedanib in cancer and IPF: A bioinformatic study16
Dihydroquercetin attenuates lipopolysaccharide-induced acute lung injury through modulating FOXO3-mediated NF-κB signaling via miR-132–3p16
Rapid effect of benralizumab for severe asthma with chronic rhinosinusitis with nasal polyps15
CXCR1 correlates to poor outcomes of EGFR-TKI against advanced non-small cell lung cancer by activating chemokine and JAK/STAT pathway14
Comparative anti-inflammatory effect of curcumin at air-liquid interface and submerged conditions using lipopolysaccharide stimulated human lung epithelial A549 cells14
Efficacy and safety of combined isoniazid-rifampicin-pyrazinamide-levofloxacin dry powder inhaler in treatment of pulmonary tuberculosis: A randomized controlled trial14
Chrysin prevents lipopolysaccharide-induced acute lung injury in mice by suppressing the IRE1α/TXNIP/NLRP3 pathway14
Inhaled delivery of a lipid nanoparticle encapsulated messenger RNA encoding a ciliary protein for the treatment of primary ciliary dyskinesia13
A randomized, double-blind study to compare the efficacy and safety of two doses of mometasone furoate delivered via Breezhaler® or Twisthaler® in patients with asthma13
Long non-coding RNA LINC01224 promotes progression and cisplatin resistance in non-small lung cancer by sponging miR-246713
Effectiveness of mepolizumab therapy in patients with severe eosinophilic asthma: Austrian real-life data13
Gentiopicroside ameliorates ovalbumin-induced airway inflammation in a mouse model of allergic asthma via regulating SIRT1/NF-κB signaling pathway13
Are short courses of antibiotic therapy as effective as standard courses for COPD exacerbations? A systematic review and meta-analysis13
Development of an inhaled anti-TSLP therapy for asthma12
An overview of the biology of a long-acting inhaled treprostinil prodrug11
Effect of piperlongumine during exposure to cigarette smoke reduces inflammation and lung injury11
Clofazimine for treatment of multidrug-resistant non-tuberculous mycobacteria11
The inflammatory regulation of TRPA1 expression in human A549 lung epithelial cells11
Effects of sildenafil on right ventricle remodelling in Portopulmonary hypertension11
Epimedin C modulates the balance between Th9 cells and Treg cells through negative regulation of noncanonical NF-κB pathway and MAPKs activation to inhibit airway inflammation in the ovalbumin–induced10
Investigating the effect of TRPV4 inhibition on pulmonary-vascular barrier permeability following segmental endotoxin challenge10
The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on lipopolysaccharide-induced airway inflammation in mice10
Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-199
Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohort9
Tolerability of nintedanib-related diarrhea in patients with idiopathic pulmonary fibrosis9
Inhalation: A means to explore and optimize nintedanib's pharmacokinetic/pharmacodynamic relationship9
“The possible implication of endothelin in the pathology of COVID-19-induced pulmonary hypertension”9
Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate following once-daily inhalation as a combination in healthy subjects8
The ALPACA study: (In)Appropriate LAMA prescribing in asthma: A cohort analysis8
Leukotriene inhibition and the risk of lung cancer among U.S. veterans with asthma8
Multiple single nucleotide polymorphisms of the transient receptor potential vanilloid 1 (TRPV1) genes associate with cough sensitivity to capsaicin in healthy subjects8
Real-life safety and efficacy of omalizumab in Japanese patients with severe allergic asthma who were subjected to dosing table revision or expansion: A post-marketing surveillance7
Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: A translational bench-to-bedside study7
Diallyl disulfide prevents cigarette smoke-induced emphysema in mice7
Pharmacokinetics of mometasone furoate delivered via two dry powder inhalers7
LncRNA STARD13-AS blocks lung squamous carcinoma cells growth and movement by targeting miR-1248/C3A7
Characteristics of patients with severe asthma who experienced treatment failure with omalizumab7
Determinants of response to bronchodilator in patients with cough variant asthma- A randomized, single-blinded, placebo-controlled study7
Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-197
Time-resolved proteome and transcriptome of paraquat-induced pulmonary fibrosis7
β-sitosterol targets glucocorticoid receptor to reduce airway inflammation and remodeling in allergic asthma7
HDAC8-inhibitor PCI-34051-induced exosomes inhibit human bronchial smooth muscle cell proliferation via miR-381-3p mediated TGFB37
Use of nintedanib in interstitial lung disease other than idiopathic pulmonary fibrosis: much caution is warranted6
An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome6
Evaluation of waterpipe smoke toxicity in C57BL/6 mice model6
WITHDRAWN: Oncogenic lncRNA MALAT-1 recruits E2F1 to upregulate RAD51 expression and thus promotes cell autophagy and tumor growth in non-small cell lung cancer6
CG223, a novel BET inhibitor, exerts TGF-β1-mediated antifibrotic effects in a murine model of bleomycin-induced pulmonary fibrosis6
Treatment of pulmonary hypertension in patients with Hereditary Hemorrhagic Telangiectasia – A case series and systematic review6
Impacts of deficiency in vitamin D derivatives on disease severity in adult bronchial asthma patients6
Treatment of respiratory viral infections through inhalation therapeutics: Challenges and opportunities6
Inflammatory and contractile profile in LPS-challenged equine isolated bronchi: Evidence for IL-6 as a potential target against AHR in equine asthma5
Effect of functional principle, delivery technique, and connection used on aerosol delivery from different nebulizers: An in-vitro study5
Open triple therapy for chronic obstructive pulmonary disease: Patterns of prescription, exacerbations and healthcare costs from a large Italian claims database5
The pharmacology of the prostaglandin D2 receptor 2 (DP2) receptor antagonist, fevipiprant5
Role of 20-hydroxyeicosatetraenoic acid in pulmonary hypertension and proliferation of pulmonary arterial smooth muscle cells5
Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthma5
The promoting role of Cx43 on the proliferation and migration of arterial smooth muscle cells for angiotensin II-dependent hypertension5
Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patients5
Pulmonary drug delivery for acute respiratory distress syndrome5
Inhaled bronchodilators use and clinical course of adult inpatients with Covid-19 pneumonia in Spain: A retrospective cohort study5
The small quinolone derived compound HT61 enhances the effect of tobramycin against Pseudomonas aeruginosa in vitro and in vivo4
Comparison of l-Carnitine and l-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultur4
Commercial α1-antitrypsin preparations markedly differ in their potential to inhibit the ATP-induced release of monocytic interleukin-1β4
Mechanistic insights into the amelioration effects of lipopolysaccharide-induced acute lung injury by baicalein: An integrated systems pharmacology study and experimental validation4
Haemodynamic effects of PAH-targeted therapies in pulmonary hypertension due to lung disease: A systematic review and meta-analysis4
Differential redox proteomic profiles of serum from severe asthma patients after one month of benralizumab and mepolizumab treatment4
Hypoxia-induced antizyme inhibitors 2 regulates cisplatin resistance through epithelia-mesenchymal transition pathway in non-small cell lung cancer4
May a different kinetic mode explain the high efficacy/safety profile of inhaled budesonide?4
Evaluation of the prophylactic effect of hydroxychloroquine on people in close-contact with patients with COVID-194
Evaluation of efficacy of nebulized low molecular weight heparin as an adjunctive extra treatment for acute mild-moderate asthma attack; a randomized clinical trial study4
Treprostinil palmitil, an inhaled long-acting pulmonary vasodilator, does not show tachyphylaxis with daily dosing in rats4
Statins’ still controversial role in pulmonary fibrosis: What does the evidence show?4
The roles of immune system and autoimmunity in pulmonary arterial hypertension: A review4
Effect of centrally and peripherally acting GABAB agonism on the healthy human cough reflex4
Sildenafil for idiopathic pulmonary fibrosis: A systematic review and meta-analysis4
Effects of inhaled JAK inhibitor GDC-4379 on exhaled nitric oxide and peripheral biomarkers of inflammation3
Ethnic pharmacokinetic comparison of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) between Asian and Western healthy subjects3
Esketamine inhaled as dry powder: Pharmacokinetic, pharmacodynamic and safety assessment in a preclinical study3
Magnesium lithospermate B improves pulmonary artery banding induced right ventricular dysfunction by alleviating inflammation via p38MAPK pathway3
The proliferative and anti-apoptosis functions of KGF/KGFR contributes to bronchial epithelial repair in asthma3
Preliminary study regarding the predicted body weight-based dexamethasone therapy in patients with COVID-19 pneumonia3
Reduction in asthma exacerbation rate after mepolizumab treatment initiation in patients with severe asthma: A real-world database study in Japan3
Comparing the outcomes of intrapleural fibrinolytic and DNase therapy versus intrapleural fibrinolytic or DNase therapy: A systematic review and meta-analysis3
Protective effects of adipose-derived biogenic nanoparticles on the pulmonary microvascular endothelial barrier in mice with ventilator-induced lung injury via the TRPV4/ROCK1 signalling pathway3
Serum dipeptidyl peptidase-4 and eosinophil cationic protein levels in patients of bronchial asthma3
Risk factors associated with increased discontinuation rate of trimethoprim–sulfamethoxazole used as a primary prophylaxis for Pneumocystis pneumonia: A retrospective cohort study3
Dual use of bronchodilators versus monotherapy, and its impact on pulmonary rehabilitation in COPD patients3
Management of severe asthma during the first lockdown phase of SARS-CoV-2 pandemic: Tips for facing the second wave3
Pyrroloquinoline quinone (PQQ) improves pulmonary hypertension by regulating mitochondrial and metabolic functions3
Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality3
Which LABA/LAMA should be chosen in COPD patients in real life?3
Eucalyptol reduces airway hyperresponsiveness in rats following cigarette smoke-exposed3
SRSF1 promotes ASMC proliferation in asthma by competitively binding CCND2 with miRNA-135a2
Differential effects of dexamethasone and roflumilast on asthma in mice with or without short cigarette smoke exposure2
Genetic variants in MIR2113 and MIR129-LEP are associated with the susceptibility of COPD in the Chinese Han population2
QA project: Hemodynamic safety of endobronchial administration of phenylephrine for control of airway bleeding by bronchoscopy2
Patients with moderate to severe COVID-19 outcomes on remdesivir according to baseline 4C mortality score2
Current and emerging treatment options for lung cancer in patients with pre-existing connective tissue disease2
Demethyleneberberine alleviates Pseudomonas aeruginosa-induced acute pneumonia by inhibiting the AIM2 inflammasome and oxidative stress2
Using prednisolone and cortisol assays to assess adherence in oral corticosteroid dependant asthma: An analysis of test-retest repeatability2
A retro-inverso modified peptide alleviated ovalbumin-induced asthma model by affecting glycerophospholipid and purine metabolism of immune cells2
Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis2
TPMT and HLA-DQA1-HLA-DRB genetic profiling to guide the use of azathioprine in the treatment of interstitial lung disease: First experience2
The impact of SARS-COV2 pandemic on the management oF IPF patients: Our narrative experience2
Pharmacokinetics and exposure-efficacy relationships of omalizumab in patients with nasal polyps2
Effectiveness of inhalation technique assessment service for patients with Respimat® inhaler2
Corrigendum to “Myricetin inhibits TNF-α-induced inflammation in A549 cells via the SIRT1/NF-κB pathway” [Pulm. Pharmacol. Therapeut. 65 (2020) 102000]2
Safety and pharmacokinetic profile of pretomanid in healthy Chinese adults: Results of a phase I single dose escalation study2
Nebulized amphotericin B for preventing exacerbations in allergic bronchopulmonary aspergillosis: A systematic review and meta-analysis2
A phase 1, randomized study to evaluate safety, tolerability, and pharmacokinetics of GDC-3280, a potential novel anti-fibrotic small molecule, in healthy subjects2
Safety and usefulness of nebulized liposomal amphotericin B: Systematic scoping review2
Bioequivalence studies of inhaled indacaterol maleate in healthy Chinese volunteers under gastrointestinal non-blocking or blocking with concomitant charcoal administration2
0.015758991241455